Recruiting Dravet Syndrome Studies in Wilmington
About Dravet Syndrome Clinical Trials in Wilmington
Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.
There are currently 1 dravet syndrome clinical trials recruiting participants in Wilmington, DELAWARE. These studies are seeking a combined 150 participants. Research is being sponsored by Epygenix. Clinical trial participation is free and participants receive study-related medical care at no cost.
Dravet Syndrome Clinical Trials in Wilmington — FAQ
Are there dravet syndrome clinical trials in Wilmington?
Yes, there are 1 dravet syndrome clinical trials currently recruiting in Wilmington, DELAWARE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Wilmington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.
Are clinical trials in Wilmington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.
What dravet syndrome treatments are being tested?
The 1 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov